Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
VMF
0
Canada
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. Ferinject
2. Injectafer
3. Iron Carboxymaltose
4. Iron Dextri-maltose
5. Polynuclear Iron (iii)-hydroxide 4(r)-(poly-(1->4)-o-alpha-d-glucopyranosyl)-oxy-2(r),3(s),5(r), 6-tetrahydroxy-hexanoate
6. Vit 45
7. Vit-45
1. 9007-72-1
2. Ex-a3450
3. (2s,3s,4s,5r)-4-[(2r,3r,4r,5s,6r)-5-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoate;iron(3+);oxygen(2-);hydroxide;hydrate
Molecular Weight | 788.4 g/mol |
---|---|
Molecular Formula | C24H44FeO25- |
Hydrogen Bond Donor Count | 16 |
Hydrogen Bond Acceptor Count | 25 |
Rotatable Bond Count | 13 |
Exact Mass | 788.152102 g/mol |
Monoisotopic Mass | 788.152102 g/mol |
Topological Polar Surface Area | 382 Ų |
Heavy Atom Count | 50 |
Formal Charge | -1 |
Complexity | 940 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 19 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
1 of 2 | |
---|---|
Drug Name | Injectafer |
PubMed Health | ferric carboxymaltose |
Drug Classes | Iron Supplement |
Drug Label | Ferric carboxymaltose, an iron replacement product, is an iron carbohydrate complex with the chemical name of polynuclear iron (III) hydroxide 4(R)-(poly-(14)-O--D-glucopyranosyl)-oxy-2(R),3(S),5(R),6-tetrahydroxy-hexanoate. It has a relative mo... |
Active Ingredient | Ferric carboxymaltose |
Dosage Form | Injectable |
Route | Intravenous |
Strength | 750mg iron/15ml (50mg iron/ml) |
Market Status | Prescription |
Company | Luitpold |
Patent | 7612109; 7754702 |
2 of 2 | |
---|---|
Drug Name | Injectafer |
PubMed Health | ferric carboxymaltose |
Drug Classes | Iron Supplement |
Drug Label | Ferric carboxymaltose, an iron replacement product, is an iron carbohydrate complex with the chemical name of polynuclear iron (III) hydroxide 4(R)-(poly-(14)-O--D-glucopyranosyl)-oxy-2(R),3(S),5(R),6-tetrahydroxy-hexanoate. It has a relative mo... |
Active Ingredient | Ferric carboxymaltose |
Dosage Form | Injectable |
Route | Intravenous |
Strength | 750mg iron/15ml (50mg iron/ml) |
Market Status | Prescription |
Company | Luitpold |
Patent | 7612109; 7754702 |
Ferric carboxymaltose is a iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron or those who have non-dialysis dependent chronic kidney disease.
FDA Label
When measured using positron emission tomography (PET), the red cell uptake of 59-Fe and 52-Fe from INJECTAFER ranged from 61% to 99%. In patients with iron deficiency, the red cell uptake ranged from 91% to 99%. In patients with renal anemia, the red cell uptake ranged from 61% to 84%.
Absorption
When a single dose of 100 to 1000 mg of iron was given to iron deficient patients, the maximum serum concentration (Cmax) was 37 g/mL to 333 g/mL. These levels were obtained 15 minutes to 1.21 hours post dose (Tmax).
Route of Elimination
Renal elimination of iron was negligible.
Volume of Distribution
3 L
7 to 12 hours.
Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that release iron.
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-12-17
Pay. Date : 2024-09-04
DMF Number : 38006
Submission : 2024-07-17
Status : Active
Type : II
NDC Package Code : 64552-4070
Start Marketing Date : 2013-07-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-10-18
Pay. Date : 2023-07-06
DMF Number : 38204
Submission : 2023-03-29
Status : Active
Type : II
NDC Package Code : 71796-054
Start Marketing Date : 2023-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-10
Pay. Date : 2018-08-13
DMF Number : 33038
Submission : 2018-08-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39631
Submission : 2024-03-18
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-10-05
Pay. Date : 2023-08-29
DMF Number : 35529
Submission : 2023-03-24
Status : Active
Type : II
NDC Package Code : 69766-093
Start Marketing Date : 2023-03-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
GDUFA
DMF Review : Complete
Rev. Date : 2024-12-17
Pay. Date : 2024-09-04
DMF Number : 38006
Submission : 2024-07-17
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-18
Pay. Date : 2023-07-06
DMF Number : 38204
Submission : 2023-03-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36795
Submission : 2022-03-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37389
Submission : 2022-07-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-05-04
Pay. Date : 2023-02-24
DMF Number : 38062
Submission : 2023-02-21
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35442
Submission : 2020-12-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39631
Submission : 2024-03-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-19
Pay. Date : 2018-05-02
DMF Number : 32437
Submission : 2018-03-29
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-05
Pay. Date : 2023-08-29
DMF Number : 35529
Submission : 2023-03-24
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-10
Pay. Date : 2018-08-13
DMF Number : 33038
Submission : 2018-08-02
Status : Active
Type : II
Registration Number : 229MF10211
Registrant's Address : Rechenstrasse 37, CH-9001 St. Gallen
Initial Date of Registration : 2017-12-01
Latest Date of Registration : 2023-10-04
Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.
About the Company : Interquim, founded in 1978, is now part of the Ferrer HealthTech division. Interquim specializes in the development of competitive processes for manufacturing high added-value APIs...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
About the Company : Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
About the Company : Specializing in natural & oncology APIs, we establish R&D and production platforms for new salt, crystal form & synthetic biology research. We cooperate with clients for IND, NDA, ...
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...
About the Company : Lee helps you focus on the business results that matter to your company. Over the years, we have leveraged our position in the global market with an enviable list of clients and a ...
About the Company : Livmore Life Sciences Pvt. Ltd., established in 2016, is a pharmaceutical company dedicated to the development, optimization, and manufacturing of high-quality Active Pharmaceutica...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
RLD : Yes
TE Code :
Brand Name : INJECTAFER
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 750MG IRON/15ML (50MG IRON/ML)
Approval Date : 2013-07-25
Application Number : 203565
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : INJECTAFER
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 500MG IRON/10ML (50MG IRON/ML)
Approval Date : 2020-10-08
Application Number : 203565
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : INJECTAFER
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1GM IRON/20ML (50MG IRON/ML)
Approval Date : 2021-04-28
Application Number : 203565
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : INJECTAFER
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 100MG IRON/2ML (50MG IRON/ML)
Approval Date : 2022-02-04
Application Number : 203565
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Global Sales Information
Market Place
Reply
20 Jul 2024
Reply
28 Jul 2023
Reply
19 Apr 2023
Reply
01 Jul 2022
Reply
21 Jun 2022
Reply
01 Apr 2022
Reply
19 Feb 2022
Reply
08 Jan 2022
Reply
31 Dec 2021
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Ferric Carboxymaltose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferric Carboxymaltose, including repackagers and relabelers. The FDA regulates Ferric Carboxymaltose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferric Carboxymaltose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ferric Carboxymaltose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ferric Carboxymaltose supplier is an individual or a company that provides Ferric Carboxymaltose active pharmaceutical ingredient (API) or Ferric Carboxymaltose finished formulations upon request. The Ferric Carboxymaltose suppliers may include Ferric Carboxymaltose API manufacturers, exporters, distributors and traders.
click here to find a list of Ferric Carboxymaltose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ferric Carboxymaltose DMF (Drug Master File) is a document detailing the whole manufacturing process of Ferric Carboxymaltose active pharmaceutical ingredient (API) in detail. Different forms of Ferric Carboxymaltose DMFs exist exist since differing nations have different regulations, such as Ferric Carboxymaltose USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ferric Carboxymaltose DMF submitted to regulatory agencies in the US is known as a USDMF. Ferric Carboxymaltose USDMF includes data on Ferric Carboxymaltose's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ferric Carboxymaltose USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ferric Carboxymaltose suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ferric Carboxymaltose Drug Master File in Japan (Ferric Carboxymaltose JDMF) empowers Ferric Carboxymaltose API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ferric Carboxymaltose JDMF during the approval evaluation for pharmaceutical products. At the time of Ferric Carboxymaltose JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ferric Carboxymaltose suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ferric Carboxymaltose Drug Master File in Korea (Ferric Carboxymaltose KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ferric Carboxymaltose. The MFDS reviews the Ferric Carboxymaltose KDMF as part of the drug registration process and uses the information provided in the Ferric Carboxymaltose KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ferric Carboxymaltose KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ferric Carboxymaltose API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ferric Carboxymaltose suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ferric Carboxymaltose as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ferric Carboxymaltose API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ferric Carboxymaltose as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ferric Carboxymaltose and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ferric Carboxymaltose NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ferric Carboxymaltose suppliers with NDC on PharmaCompass.
Ferric Carboxymaltose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ferric Carboxymaltose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferric Carboxymaltose GMP manufacturer or Ferric Carboxymaltose GMP API supplier for your needs.
A Ferric Carboxymaltose CoA (Certificate of Analysis) is a formal document that attests to Ferric Carboxymaltose's compliance with Ferric Carboxymaltose specifications and serves as a tool for batch-level quality control.
Ferric Carboxymaltose CoA mostly includes findings from lab analyses of a specific batch. For each Ferric Carboxymaltose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ferric Carboxymaltose may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferric Carboxymaltose EP), Ferric Carboxymaltose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferric Carboxymaltose USP).
LOOKING FOR A SUPPLIER?